Literature DB >> 19812276

Evaluation of hepatitis C virus core antigen assays in detecting recombinant viral antigens of various genotypes.

Mohsan Saeed1, Ryosuke Suzuki, Madoka Kondo, Hideki Aizaki, Takanobu Kato, Toshiaki Mizuochi, Takaji Wakita, Haruo Watanabe, Tetsuro Suzuki.   

Abstract

A single substitution within the hepatitis C virus core antigen sequence, A48T, which is observed in approximately 30% of individuals infected with genotype 2a virus, reduces the sensitivity of a commonly used chemiluminescence enzyme immunoassay. Quantitation of the antigen is improved by using a distinct anticore antibody with a different epitope.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19812276      PMCID： PMC2786616          DOI： 10.1128/JCM.01437-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Full-length complementary DNA of hepatitis C virus genome from an infectious blood sample.

Authors:  H Aizaki; Y Aoki; T Harada; K Ishii; T Suzuki; S Nagamori; G Toda; Y Matsuura; T Miyamura
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

2.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

3.  Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase.

Authors:  C Micha Nübling; Gabriele Unger; Michael Chudy; Steven Raia; Johannes Löwer
Journal:  Transfusion       Date:  2002-08       Impact factor: 3.157

4.  Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.

Authors:  E Tanaka; C Ohue; K Aoyagi; K Yamaguchi; S Yagi; K Kiyosawa; H J Alter
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

Review 5.  Hepatitis C viral life cycle.

Authors:  Tetsuro Suzuki; Koji Ishii; Hideki Aizaki; Takaji Wakita
Journal:  Adv Drug Deliv Rev       Date:  2007-08-09       Impact factor: 15.470

6.  Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users.

Authors:  Dale M Netski; Xiao-Hong Wang; Shruti H Mehta; Kenrad Nelson; David Celentano; Satawat Thongsawat; Niwat Maneekarn; Vinai Suriyanon; Jaroon Jittiwutikorn; David L Thomas; John R Ticehurst
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.

Authors:  W K Roth; M Weber; E Seifried
Journal:  Lancet       Date:  1999-01-30       Impact factor: 79.321

8.  Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin.

Authors:  Maria Buti; Claudia Mendez; Melanie Schaper; Silvia Sauleda; Auristela Valdes; Francisco Rodriguez-Frias; Rosendo Jardi; Rafael Esteban
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

9.  Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.

Authors:  Magali Bouvier-Alias; Keyur Patel; Harel Dahari; Stéphanie Beaucourt; Patrick Larderie; Lawrence Blatt; Christophe Hezode; Gaston Picchio; Daniel Dhumeaux; Avidan U Neumann; John G McHutchison; Jean-Michel Pawlotsky
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

10.  Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy.

Authors:  M Maynard; P Pradat; P Berthillon; G Picchio; N Voirin; M Martinot; P Marcellin; C Trepo
Journal:  J Viral Hepat       Date:  2003-07       Impact factor: 3.728
View more
  4 in total

1.  Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone.

Authors:  Tomoko Date; Takanobu Kato; Junko Kato; Hitoshi Takahashi; Kenichi Morikawa; Daisuke Akazawa; Asako Murayama; Keiko Tanaka-Kaneko; Tetsutaro Sata; Yasuhito Tanaka; Masashi Mizokami; Takaji Wakita
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

2.  Japanese reference panel of blood specimens for evaluation of hepatitis C virus RNA and core antigen quantitative assays.

Authors:  Asako Murayama; Nao Sugiyama; Koichi Watashi; Takahiro Masaki; Ryosuke Suzuki; Hideki Aizaki; Toshiaki Mizuochi; Takaji Wakita; Takanobu Kato
Journal:  J Clin Microbiol       Date:  2012-04-11       Impact factor: 5.948

3.  Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia.

Authors:  Sabino Russi; Domenico Sansonno; Maria Addolorata Mariggiò; Angela Vinella; Fabio Pavone; Gianfranco Lauletta; Silvia Sansonno; Franco Dammacco
Journal:  Arthritis Res Ther       Date:  2014-03-18       Impact factor: 5.156

4.  Performance Evaluation of In Vitro Screening and Diagnostic Kits for Hepatitis C Virus Infection.

Authors:  Asako Murayama; Haruka Momose; Norie Yamada; Keiji Matsubayashi; Masamichi Muramatsu; Isao Hamaguchi; Takanobu Kato
Journal:  Front Cell Infect Microbiol       Date:  2022-02-03       Impact factor: 5.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.